Bristol-Myers Squibb Co. (BMY) PT Lowered to $62 at Truist Securities
Truist Securities analyst Robyn Karnauskas ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
